Indaptus Therapeutics, Inc.
INDP
$6.52
-$0.55-7.78%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.16M | 3.89M | 5.79M | 7.38M | 7.30M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 252.70K | 669.70K | 681.60K | 236.60K | 180.40K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.70K | 400.20K | 150.00K | 12.10K | 6.30K |
| Total Current Assets | 6.41M | 4.96M | 6.62M | 7.63M | 7.49M |
|
|
|||||
| Total Current Assets | 6.41M | 4.96M | 6.62M | 7.63M | 7.49M |
| Net Property, Plant & Equipment | 33.60K | 58.10K | 82.20K | 105.70K | 128.60K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 392.60K | 392.60K | 638.30K | 504.70K | 504.70K |
| Total Assets | 6.84M | 5.41M | 7.34M | 8.24M | 8.12M |
|
|
|||||
| Total Accounts Payable | 618.50K | 1.31M | 870.20K | 555.90K | 416.60K |
| Total Accrued Expenses | 1.36M | 1.24M | 2.44M | 1.57M | 1.41M |
| Short-term Debt | 6.50M | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 34.40K | 59.50K | 84.20K | 104.00K | 103.20K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 8.51M | 2.61M | 3.39M | 2.23M | 1.93M |
|
|
|||||
| Total Current Liabilities | 8.51M | 2.61M | 3.39M | 2.23M | 1.93M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 6.50M | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | 4.00K | 27.60K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 8.51M | 2.61M | 3.39M | 2.24M | 1.96M |
|
|
|||||
| Common Stock & APIC | 68.53M | 67.77M | 64.38M | 62.31M | 59.41M |
| Retained Earnings | -70.20M | -64.97M | -60.44M | -56.31M | -53.24M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -1.67M | 2.80M | 3.94M | 6.00M | 6.17M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1.67M | 2.80M | 3.94M | 6.00M | 6.17M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.67M | 2.80M | 3.94M | 6.00M | 6.17M |
|
|
|||||